Abstract
Background:Epithelial cell adhesion molecule (EpCAM)-based enumeration of circulating tumor cells (CTC) has prognostic value in patients with solid tumors, such as advanced breast, colon, and prostate cancer. However, poor sensitivity has been reported for non-small cell lung cancer (NSCLC). To address this problem, we developed a microcavity array (MCA) system integrated with a miniaturized device for CTC isolation without relying on EpCAM expression. Here, we report the results of a clinical study on CTCs of advanced lung cancer patients in which we compared the MCA system with the CellSearch system, which employs the conventional EpCAM-based method.Methods:Paired peripheral blood samples were collected from 43 metastatic lung cancer patients to enumerate CTCs using the CellSearch system according to the manufacturer's protocol and the MCA system by immunolabeling and cytomorphological analysis. The presence of CTCs was assessed blindly and independently by both systems.Results:CTCs were detected in 17 of 22 NSCLC patients using the MCA system versus 7 of 22 patients using the CellSearch system. On the other hand, CTCs were detected in 20 of 21 small cell lung cancer (SCLC) patients using the MCA system versus 12 of 21 patients using the CellSearch system. Significantly more CTCs in NSCLC patients were detected by the MCA system (median 13, range 0-291 cells/7.5 mL) than by the CellSearch system (median 0, range 0-37 cells/7.5 ml) demonstrating statistical superiority (p = 0.0015). Statistical significance was not reached in SCLC though the trend favoring the MCA system over the CellSearch system was observed (p = 0.2888). The MCA system also isolated CTC clusters from patients who had been identified as CTC negative using the CellSearch system.Conclusions:The MCA system has a potential to isolate significantly more CTCs and CTC clusters in advanced lung cancer patients compared to the CellSearch system.
| Original language | English |
|---|---|
| Article number | e67466 |
| Journal | PLoS One |
| Volume | 8 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 2013 Jun 28 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Agricultural and Biological Sciences(all)
- Biochemistry, Genetics and Molecular Biology(all)
- Medicine(all)
Cite this
Size-Based Isolation of Circulating Tumor Cells in Lung Cancer Patients Using a Microcavity Array System. / Hosokawa, Masahito; Kenmotsu, Hirotsugu; Koh, Yasuhiro; Yoshino, Tomoko; Yoshikawa, Takayuki; Naito, Tateaki; Takahashi, Toshiaki; Murakami, Haruyasu; Nakamura, Yukiko; Tsuya, Asuka; Shukuya, Takehito; Ono, Akira; Akamatsu, Hiroaki; Watanabe, Reiko; Ono, Sachiyo; Mori, Keita; Kanbara, Hisashige; Yamaguchi, Ken; Tanaka, Tsuyoshi; Matsunaga, Tadashi; Yamamoto, Nobuyuki.
In: PLoS One, Vol. 8, No. 6, e67466, 28.06.2013.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Size-Based Isolation of Circulating Tumor Cells in Lung Cancer Patients Using a Microcavity Array System
AU - Hosokawa, Masahito
AU - Kenmotsu, Hirotsugu
AU - Koh, Yasuhiro
AU - Yoshino, Tomoko
AU - Yoshikawa, Takayuki
AU - Naito, Tateaki
AU - Takahashi, Toshiaki
AU - Murakami, Haruyasu
AU - Nakamura, Yukiko
AU - Tsuya, Asuka
AU - Shukuya, Takehito
AU - Ono, Akira
AU - Akamatsu, Hiroaki
AU - Watanabe, Reiko
AU - Ono, Sachiyo
AU - Mori, Keita
AU - Kanbara, Hisashige
AU - Yamaguchi, Ken
AU - Tanaka, Tsuyoshi
AU - Matsunaga, Tadashi
AU - Yamamoto, Nobuyuki
PY - 2013/6/28
Y1 - 2013/6/28
N2 - Background:Epithelial cell adhesion molecule (EpCAM)-based enumeration of circulating tumor cells (CTC) has prognostic value in patients with solid tumors, such as advanced breast, colon, and prostate cancer. However, poor sensitivity has been reported for non-small cell lung cancer (NSCLC). To address this problem, we developed a microcavity array (MCA) system integrated with a miniaturized device for CTC isolation without relying on EpCAM expression. Here, we report the results of a clinical study on CTCs of advanced lung cancer patients in which we compared the MCA system with the CellSearch system, which employs the conventional EpCAM-based method.Methods:Paired peripheral blood samples were collected from 43 metastatic lung cancer patients to enumerate CTCs using the CellSearch system according to the manufacturer's protocol and the MCA system by immunolabeling and cytomorphological analysis. The presence of CTCs was assessed blindly and independently by both systems.Results:CTCs were detected in 17 of 22 NSCLC patients using the MCA system versus 7 of 22 patients using the CellSearch system. On the other hand, CTCs were detected in 20 of 21 small cell lung cancer (SCLC) patients using the MCA system versus 12 of 21 patients using the CellSearch system. Significantly more CTCs in NSCLC patients were detected by the MCA system (median 13, range 0-291 cells/7.5 mL) than by the CellSearch system (median 0, range 0-37 cells/7.5 ml) demonstrating statistical superiority (p = 0.0015). Statistical significance was not reached in SCLC though the trend favoring the MCA system over the CellSearch system was observed (p = 0.2888). The MCA system also isolated CTC clusters from patients who had been identified as CTC negative using the CellSearch system.Conclusions:The MCA system has a potential to isolate significantly more CTCs and CTC clusters in advanced lung cancer patients compared to the CellSearch system.
AB - Background:Epithelial cell adhesion molecule (EpCAM)-based enumeration of circulating tumor cells (CTC) has prognostic value in patients with solid tumors, such as advanced breast, colon, and prostate cancer. However, poor sensitivity has been reported for non-small cell lung cancer (NSCLC). To address this problem, we developed a microcavity array (MCA) system integrated with a miniaturized device for CTC isolation without relying on EpCAM expression. Here, we report the results of a clinical study on CTCs of advanced lung cancer patients in which we compared the MCA system with the CellSearch system, which employs the conventional EpCAM-based method.Methods:Paired peripheral blood samples were collected from 43 metastatic lung cancer patients to enumerate CTCs using the CellSearch system according to the manufacturer's protocol and the MCA system by immunolabeling and cytomorphological analysis. The presence of CTCs was assessed blindly and independently by both systems.Results:CTCs were detected in 17 of 22 NSCLC patients using the MCA system versus 7 of 22 patients using the CellSearch system. On the other hand, CTCs were detected in 20 of 21 small cell lung cancer (SCLC) patients using the MCA system versus 12 of 21 patients using the CellSearch system. Significantly more CTCs in NSCLC patients were detected by the MCA system (median 13, range 0-291 cells/7.5 mL) than by the CellSearch system (median 0, range 0-37 cells/7.5 ml) demonstrating statistical superiority (p = 0.0015). Statistical significance was not reached in SCLC though the trend favoring the MCA system over the CellSearch system was observed (p = 0.2888). The MCA system also isolated CTC clusters from patients who had been identified as CTC negative using the CellSearch system.Conclusions:The MCA system has a potential to isolate significantly more CTCs and CTC clusters in advanced lung cancer patients compared to the CellSearch system.
UR - http://www.scopus.com/inward/record.url?scp=84879529278&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84879529278&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0067466
DO - 10.1371/journal.pone.0067466
M3 - Article
C2 - 23840710
AN - SCOPUS:84879529278
VL - 8
JO - PLoS One
JF - PLoS One
SN - 1932-6203
IS - 6
M1 - e67466
ER -